Cargando…
Evidence for Positive Selection in the C-terminal Domain of the Cholesterol Metabolism Gene PCSK9 Based on Phylogenetic Analysis in 14 Primate Species
BACKGROUND: Cholesterol homeostasis is maintained through finely tuned mechanisms regulating intestinal absorption, hepatic biosynthesis and secretion as well as plasma clearance. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted enzyme of the serine protease family that reduces ce...
Autores principales: | Ding, Keyue, McDonough, Samantha J., Kullo, Iftikhar J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034530/ https://www.ncbi.nlm.nih.gov/pubmed/17971861 http://dx.doi.org/10.1371/journal.pone.0001098 |
Ejemplares similares
-
Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain
por: Poirier, Steve, et al.
Publicado: (2016) -
Patterns of population differentiation of candidate genes for cardiovascular disease
por: Kullo, Iftikhar J, et al.
Publicado: (2007) -
Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease
por: Ding, Keyue, et al.
Publicado: (2011) -
The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017) -
Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding
por: Sarkar, Samantha K., et al.
Publicado: (2022)